|
KLHL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.561780E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.044400E-01 |
| Normal-vs-Stage2 |
8.861800E-02 |
| Normal-vs-Stage3 |
1.043510E-04 |
| Normal-vs-Stage4 |
4.551900E-04 |
| Stage1-vs-Stage2 |
7.856000E-02 |
| Stage1-vs-Stage3 |
7.65520000000075E-05 |
| Stage1-vs-Stage4 |
5.232600E-04 |
| Stage2-vs-Stage3 |
3.019200E-01 |
| Stage2-vs-Stage4 |
3.330800E-01 |
| Stage3-vs-Stage4 |
9.786800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.408400E-02 |
| Normal-vs-AfricanAmerican |
2.149900E-02 |
| Normal-vs-Asian |
8.858800E-01 |
| Caucasian-vs-AfricanAmerican |
2.818200E-01 |
| Caucasian-vs-Asian |
4.226600E-01 |
| AfricanAmerican-vs-Asian |
2.756400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.107800E-02 |
| Normal-vs-Female |
4.359700E-02 |
| Male-vs-Female |
9.249800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.365600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.909200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.097600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.762700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.125200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.793400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.818220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.660400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.917100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.115780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.973900E-02 |
| Normal-vs-Grade 2 |
9.068800E-01 |
| Normal-vs-Grade 3 |
6.1570999999927E-05 |
| Normal-vs-Grade 4 |
2.200400E-04 |
| Grade 1-vs-Grade 2 |
2.766000E-02 |
| Grade 1-vs-Grade 3 |
5.163100E-03 |
| Grade 1-vs-Grade 4 |
8.43390000000444E-05 |
| Grade 2-vs-Grade 3 |
2.41119999999651E-05 |
| Grade 2-vs-Grade 4 |
4.640300E-04 |
| Grade 3-vs-Grade 4 |
3.638800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.839200E-01 |
| Normal-vs-ccB subtype |
5.562100E-03 |
| ccA subtype-vs-ccB subtype |
1.443850E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.711870E-02 |
| Normal-vs-N1 |
3.345400E-01 |
| N0-vs-N1 |
8.061200E-01 |
|
|
